阿尔茨海默氏症的陶病理独特地影响了层深度
Samira A Maboudian1,2, Corrina S Fonseca1,2, Adam C Martersteck3
1Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, CA, USA.
Annals of neurology
|January 24, 2026
概括
阿尔茨海默病的陶氏病理优先影响大脑,特别是它们的深度. 这种的脆弱性与更强的海马连接性有关,影响大脑结构和功能.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 神经成像是一种神经成像.
背景情况:
- 已知沉积会影响阿尔茨海默病 (AD) 中的大脑结构.
- 病理影响的精确局部,特别是与旋转和状解剖学相关的,仍然不太了解.
- 调查区域的脆弱性对于理解AD的发病因子至关重要.
研究的目的:
- 为了确定阿尔茨海默病 (AD) 中的病理是否优先影响,特别是深度.
- 探索新皮层的TAU PET信号与皮层厚度之间的关系.
- 检查敏感区域与海马的功能连接.
主要方法:
- 使用MRI和PET对来自阿尔茨海默病神经成像计划 (ADNI) 的675名参与者的分析.
- 在晚期的AD病例中检查死后的MRI和酸染色.
- 在187名认知正常的成年人中休息状态功能性MRI以评估连接性.
主要成果:
- 与相关的皮质稀释主要发生在状区域,特别是最深的部分.
- 尸体解剖证实了在深处的偏好性积.
- 易受相关稀释的区域与海马体的连接性更强.
结论:
- 硫,特别是它们的深度,是结构和功能上容易受到TAU沉积的地区.
- 了解的脆弱性可以了解区域对病理的敏感性.
- 这些知识揭示了病理的有害功能和认知影响.
相关概念视频
Amyloid Fibrils
10.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.2K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
20
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Alzheimer Disease ll: Pathophysiology
32
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32
Parkinson Disease ll: Pathophysiology
22
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
22
Dementia l: Introduction
31
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
31


